Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
This study has been completed.
Study NCT00033358 Information provided by National Cancer Institute (NCI)
First Received: April 9, 2002 Last Updated: September 25, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Endometrial Cancer
Additional conditions recognized in this trial
Colonic Neoplasms
Colorectal Neoplasms, Hereditary Nonpolyposis
Endometrial Neoplasms
More general conditions related to this trial
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
DNA Repair-Deficiency Disorders
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genetic Diseases, Inborn
Genital Diseases, Female
Genital Neoplasms, Female
Intestinal Diseases
Intestinal Neoplasms
Metabolic Diseases
Neoplasms
Neoplasms by Site
Neoplastic Syndromes, Hereditary
Urogenital Neoplasms
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
ethinyl estradiol
medroxyprogesterone
norgestrel
Additional drug interventions recognized in this trial
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
